• 06 Jun 2019

SPA Healthcare - Morning Comment

Motif Bio, 0.7 | Collagen Solutions, 3.2

    • Vadim Alexandre

    • 3 pages

Stock Image


 
Stock Image


Motif Bio (MTFB.L): Further clinical trial data required for iclaprim approval | Collagen Solutions (COS.L): Result of General Meeting and Open Offer


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

SP Angel Healthcare Conditions

Companies: Motif Bio Cambridge Cognition

Collagen Solutions - Final Results

Companies: Collagen Solutions

Cenkos: Collagen Solutions Plc -- Under Review

Companies: Collagen Solutions

Life Sciences Review - The Biotech Feast - after the party comes the hangover

Companies: EDEN MTFB TILS SDI GDR IMM BMK AVO AVCT

Small Cap Feast

Companies: TMT PPS GWMO AQX ALS MCL TPG RBD COS KOD

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top